(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.
----------
AIM - WINNERS
----------
K3 Business Technology Group PLC, up 18% at 155.50 pence, 12-month range 60.01p-160p. The enterprise software company sells its managed services unit, Starcom Technologies Ltd, to Node4 Ltd, a UK-based infrastructure and services company backed by private equity investment firm, Bowmark Capital. Total consideration for deal GBP14.7 million, including GBP500,000 cash on the balance sheet, paid entirely in cash on completion. "The transaction generates a significant profit on disposal, in excess of GBP10 million, which will be accounted for as an exceptional contribution to results in the current financial year to 30 November 2021," K3 says.
----------
Aquis Exchange PLC, up 8.7% at 565.00p, 12-month range 304.03p-565.42p. The exchange services expects to report revenue of no less than GBP11.0 million for 2020, marginally ahead of market expectations. Also expects to deliver maiden full-year pre- and post-tax profit, again ahead of market forecasts. "Revenue growth has been driven in part by continued high levels of trading on Aquis Exchange alongside strong technology sales, with a number of clients having renewed licensing contracts at the end of the year, and a growth in data revenues," company says.
----------
Pires Investments PLC, up 8.3% at 14.89p, 12-month range 1.52p-17.5p. The the investment company focused on next-generation technology invests further GBP35,000 in Low6 Ltd as part of the extension of Low6's pre-IPO funding round. Low6 is a UK incorporated company that has developed a next-generation sports betting platform. Low6 plans to list in the second quarter of 2021.
----------
AIM - LOSERS
----------
Shield Therapeutics, down 20% at 44.07p, 12-month range 35p-153p. The commercial stage pharmaceutical company plans to raise up to GBP25.0 million via subscription and placing priced at 30.0 pence per share. Will also be making open offer to qualifying shareholders at the same price to raise up to GBP4.2 million. Fundraising share price represents discount of 44% to Thursday's closing price. The net proceeds of the subscription and the placing will finance the launch costs of Accrufer.
----------
By Lucy Heming;Â lucyheming@alliancenews.com
Copyright 2021 Alliance News Limited. All Rights Reserved.